UCLA Journal of Radiation Oncology SPRING 2024 - Flipbook - Page 36
UCLA RADIATION ONCOLOGY JOURNAL
SMART trial dosing regimen equates to a BED10 of 100 Gy, further highlighting the clinical advantage
of on-table adaptive planning enabled by MRgRT in this study. Importantly, the primary study objective
of demonstrating